Company Overview of Gemini Genomics Limited
Gemini Genomics plc was acquired by Sequenom, Inc. on September 20, 2001. Gemini Genomics plc engaged as a clinical genomics company that uses clinical and medical information as a starting point to identify relationships between genes and human health and disease. The company's discoveries provided it with licensable products that pharmaceutical and diagnostic companies use in drug discovery and/or gene-based diagnostic applications.
162 Science Park Milton Road
Cambridge, CB4 OGH
44 12 2343 5300
Key Executives for Gemini Genomics Limited
Gemini Genomics Limited does not have any Key Executives recorded.
Similar Private Companies By Industry
|ADC Biotechnology Ltd||Europe|
|Advanced Gel Technology Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Gemini Genomics Limited, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.